Electroconvulsive therapy for depression in Parkinson's disease: systematic review of evidence and recommendations.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Neurodegenerative Disease Management

• Publication date

  2016-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.2217/nmt-2016-0002PMID 27033556
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurocognitive Disorders in Geriatric Psychiatry.

  2017cited by this paper
• Management of Depression in Parkinson's Disease: A Systematic Review

  2017cited by this paper
• Electroconvulsive Therapy Intervention for Parkinson's Disease.

  2015cited by this paper
• Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors.

  2015cited by this paper
• Repetitive transcranial magnetic stimulation (rTMS) for the treatment of depression in Parkinson disease: a meta-analysis of randomized controlled clinical trials

  2015cited by this paper
• Rivastigmine treatment of Othello syndrome and post-ECT delirium in a patient with Parkinson's disease.

  2015cited by this paper
• A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson’s disease

  2014cited by this paper
• Quantitative evaluation of electroconvulsive therapy for Parkinson’s disease with refractory psychiatric symptoms

  2014cited by this paper
• Chronic and treatment resistant depression: diagnosis and stepwise therapy.

  2014cited by this paper
• Short- and long-term neurocognitive functioning after electroconvulsive therapy in depressed elderly: a prospective naturalistic study

  2013cited by this paper
• EFFICACY AND ACCEPTABILITY OF HIGH FREQUENCY REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (rTMS) VERSUS ELECTROCONVULSIVE THERAPY (ECT) FOR MAJOR DEPRESSION: A SYSTEMATIC REVIEW AND META‐ANALYSIS OF RANDOMIZED TRIALS

  2013cited by this paper
• Letter to the Editor: Successful Use of Electroconvulsive Therapy for Refractory Anxiety in Parkinson's Disease

  2012cited by this paper
• A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease

  2012cited by this paper
• Efficacy of ECT in severe obsessive-compulsive disorder with Parkinson’s disease

  2012cited by this paper
• Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy.

  2011cited by this paper
• Electroconvulsive treatment of a patient with Parkinson's disease and moderate depression

  2011cited by this paper
• Iodine-123 Fluoropropyl-Carbomethoxy-3-&bgr;-(4-Iodophenyltropane) Single-Photon Emission Computed Tomography Findings Before and After Electroconvulsive Therapy in Major Depressive Disorder With Parkinsonism

  2011cited by this paper
• Parkinson's disease: The quintessential neuropsychiatric disorder

  2011cited by this paper
• Efficacy and cognitive side effects of electroconvulsive therapy (ECT) in depressed elderly inpatients with coexisting mild cognitive impairment or dementia.

  2011cited by this paper
• Temporary interruption of deep brain stimulation for Parkinson's disease during outpatient electroconvulsive therapy for major depression: a novel treatment strategy.

  2011cited by this paper
• Case report of electroconvulsive therapy in a patient with Parkinson disease concomitant with deep brain stimulation.

  2011cited by this paper
• The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease

  2011cited by this paper
• Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial.

  2011cited by this paper
• Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials

  2010cited by this paper
• No evidence for switching the antidepressant: systematic review and meta‐analysis of RCTs of a common therapeutic strategy

  2010cited by this paper
• Marked Improvement of Psychotic Symptoms After Electroconvulsive Therapy in Parkinson Disease

  2010cited by this paper
• Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

  2010cited by this paper
• Bupropion as the treatment of choice in depression associated with Parkinson's disease and it's various treatments.

  2010cited by this paper
• Parkinson hastalığı, psikoz ve depresyonu olan üç olgunun elektrokonvulsif tedavi ile etkili tedavisi

  2010cited by this paper
• ECT for Parkinson's disease.

  2009cited by this paper
• A systematic review of prevalence studies of depression in Parkinson's disease

  2008cited by this paper
• Suicidal and death ideation in Parkinson's disease

  2008cited by this paper
• Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy.

  2008cited by this paper
• Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.

  2008cited by this paper
• Knowledge and Attitudes Regarding Electroconvulsive Therapy Among Medical Students and the General Public

  2008cited by this paper
• Bitemporal electroconvulsive therapy for depression in a Parkinson disease patient with a deep-brain stimulator.

  2008cited by this paper
• Depression rating scales in Parkinson's disease: Critique and recommendations

  2007cited by this paper
• Mlancolie, Parkinson et pseudo-Parkinson: propos de deux cas cliniques

  2007cited by this paper
• Ropinirole 24-hour prolonged release

  2007cited by this paper
• Antidepressant Treatment of Veterans With Parkinson's Disease and Depression: Analysis of a National Sample

  2007cited by this paper
• Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

  2006cited by this paper
• Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report

  2006cited by this paper
• Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

  2006cited by this paper
• Electroconvulsive therapy for depression in a Parkinson's disease patient with bilateral subthalamic nucleus deep brain stimulators.

  2005cited by this paper
• Electroconvulsive therapy in drug-induced psychiatric states and neuroleptic malignant syndrome.

  2005cited by this paper
• Non-invasive brain stimulation for Parkinson’s disease: a systematic review and meta-analysis of the literature

  2005cited by this paper
• A systematic review of prevalence studies of dementia in Parkinson's disease

  2005cited by this paper
• Electroconvulsive therapy in Parkinson's syndrome with “on-off” phenomenon

  2005cited by this paper
• Maintenance ECT in the treatment of PD. Therapy improves psychotic symptoms, physical function.

  2003cited by this paper
• Electroconvulsive therapy in movement disorders: an update.

  2003cited by this paper
• Control con SPECT cerebral en la terapia electroconvulsiva en pacientes con episodio depresivo grave farmacorresistente y enfermedad de Parkinson

  2002cited by this paper
• [Check-ups with brain SPECT in electroconvulsive therapy in patients with severe drug-resistant depressive episodes and Parkinson's disease].

  2002cited by this paper
• Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.

  2001cited by this paper
• ECT in Parkinson's disease – dopamine transporter visualised by [123I]-β-CIT SPECT

  2000cited by this paper
• ECT in Parkinson's disease-dopamine transporter visualised by [123I]-beta-CIT SPECT.

  2000cited by this paper
• Maintenance ECT in Parkinson's disease

  1999cited by this paper
• A naturalistic review of maintenance ECT at a university setting.

  1999cited by this paper
• [Severe therapy refractory depression as initial manifestation of Parkinson disease].

  1999cited by this paper
• Effectiveness of ECT in patients with parkinsonism.

  1998cited by this paper
• Maintenance electroconvulsive therapy for intractable Parkinson's disease.

  1998cited by this paper
• [Electroconvulsive therapy in Parkinson disease. Description of three cases].

  1997cited by this paper
• Delirium in a 75-year-old woman receiving ECT and levodopa.

  1997cited by this paper
• Maintenance electroconvulsive therapy for Parkinson's disease.

  1997cited by this paper
• Improvement in depression-related cognitive dysfunction following ECT.

  1995cited by this paper
• Combined clozapine and electroconvulsive therapy for the treatment of drug-induced psychosis in Parkinson's disease.

  1995cited by this paper
• Maintenance ECT for treatment of therapy-resistant paranoid schizophrenia and Parkinson's disease.

  1995cited by this paper
• Delusional depression in Parkinson's disease.

  1993cited by this paper
• Safety and Efficacy of ECT in Depressed Patients with Organic Brain Disease: Review of a Clinical Experience.

  1992cited by this paper
• Cognitive impairment after ECT in patients with Parkinson's disease and psychiatric illness.

  1992cited by this paper
• Depression and Parkinson's disease: a review.

  1992cited by this paper
• Dysarthria During ECT Given for Parkinson's Disease and Depression.

  1992cited by this paper
• Electroconvulsive Therapy in Parkinson's Disease: A Report on Five Cases.

  1992cited by this paper
• ECT for Refractory Parkinson's Disease.

  1991cited by this paper
• Electroconvulsive therapy in Parkinson's disease and other movement disorders

  1991cited by this paper
• ECT-induced delirium in depressed patients with Parkinson's disease.

  1991cited by this paper
• Electroconvulsive therapy in untreated Parkinson's disease

  1991cited by this paper
• Bupropion and delirium.

  1990cited by this paper
• ECT and Parkinson's disease revisited: a "naturalistic" study.

  1989cited by this paper
• ECT for Parkinson's disease.

  1989cited by this paper
• Electroconvulsive therapy in the treatment of combined depression and Parkinson's disease.

  1988cited by this paper
• ECT for Parkinson's Disease?

  1988cited by this paper
• Reporting of Technical Parameters in ECT Publications: Recommendations for Authors.

  1988cited by this paper
• Dissociation of motor response from mood and cognition in a parkinsonian patient treated with ECT.

  1985cited by this paper
• Parkinsonism: improvement by electroconvulsive therapy.

  1983cited by this paper
• Effects of electroconvulsive therapy on mood, parkinsonism, and tardive dyskinesia in a depressed patient: ECT and dopamine systems.

  1983cited by this paper
• Parkinson's disease, depression, and electroconvulsive therapy: a clinical and neurobiologic synthesis.

  1979cited by this paper
• [Depressive pictures in Parkinson disease treated with electroshock].

  1978cited by this paper
• Parkinson's disease, depression, and ECT: a review and case study.

  1977cited by this paper
• Improvement of depression and parkinsonism during ECT: a case study.

  1976cited by this paper
• Improvement of Parkinsonism in depressed patients treated with ECT.

  1975cited by this paper
• Letter: Electroconvulsive therapy in patients with parkinsonism.

  1975cited by this paper
• Improvement of Parkinsonism in depressed patients treated with ECT.

  1975cited by this paper

• Depression in Parkinson’s disease: aetiology, assessment and treatment

  2026cites this paper
• Treatment Approaches To Anxiety and Depression in Parkinson’s Disease

  2025cites this paper
• Treatment options for depression in Parkinson's disease: a mini-review.

  2025cites this paper
• Multicenter Observational Study of Electroconvulsive Therapy in Japan

  2024cites this paper
• Non-Pharmacological Interventions for Depression and Anxiety in Parkinson’s Disease

  2024cites this paper
• Neurobiology of Depression in Parkinson's disease: Insights into Epidemiology, Molecular Mechanisms and Treatment Strategies.

  2023cites this paper
• Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review

  2023influential citation
• A look back at the prodromal findings in Parkinson’s disease

  2023cites this paper
• Electroconvulsive Seizure Normalizes Motor Deficits and Induces Autophagy Signaling in the MPTP-Induced Parkinson Disease Mouse Model

  2023cites this paper
• Cognitive dysfunction and neuropsychiatric aspects of Parkinson's disease.

  2022cites this paper
• When Is Being Sad on the Burn Unit Pathological? Differential Diagnosis of Demoralization, Adjustment Disorder and Major Depressive Disorder in Burn Survivors

  2022cites this paper
• Scope of add on repetitive transcranial magnetic stimulation in treating depression in Parkinson’s disease

  2022cites this paper
• Catatonia in two women with Parkinson’s disease treated with electroconvulsive therapy

  2022cites this paper
• Should patients with Parkinson’s disease only visit a neurologist’s office? - a narrative review of neuropsychiatric disorders among people with Parkinson’s disease

  2022cites this paper
• Electroconvulsive therapy improves psychotic symptoms in patients with dementia with Lewy bodies

  2022cites this paper
• Depression in Parkinson's Disease: A Narrative Review

  2022cites this paper
• Electroconvulsive Therapy in Psychiatric Disorders: A Narrative Review Exploring Neuroendocrine–Immune Therapeutic Mechanisms and Clinical Implications

  2022cites this paper
• Depression in Patients with Parkinson’s Disease: Current Understanding of its Neurobiology and Implications for Treatment

  2022cites this paper
• Altered Brain Activity in Depression of Parkinson’s Disease: A Meta-Analysis and Validation Study

  2022cites this paper
• Focus on Depression in Parkinson's Disease: A Delphi Consensus of Experts in Psychiatry, Neurology, and Geriatrics

  2021cites this paper
• Emerging Perspectives in the Diagnosis and Management of Depression and Psychosis in Parkinson's Disease

  2021cites this paper
• Interventional Psychiatry

  2021cites this paper
• Challenges during Electroconvulsive Therapy—A Review

  2021cites this paper
• Clinical features and predictors of non-response in severe catatonic patients treated with electroconvulsive therapy

  2021cites this paper
• Clozapine: Why Is It So Uniquely Effective in the Treatment of a Range of Neuropsychiatric Disorders?

  2021cites this paper
• Mood Disorders and Anxiety in Parkinson’s Disease: Current Concepts

  2021cites this paper
• Optimal Treatment of Depression and Anxiety in Parkinson's Disease.

  2021cites this paper
• Psychiatric, Motor, and Autonomic Effects of Bifrontal ECT in Depressed Parkinson's Disease Patients.

  2021cites this paper
• Depression Comorbid With Stroke, Traumatic Brain Injury, Parkinson's Disease, and Multiple Sclerosis: Diagnosis and Treatment.

  2020cites this paper
• Electroconvulsive Therapy in Geriatric Psychiatry: A Selective Review.

  2020cites this paper
• Non-motor Symptoms in Parkinson’s Disease

  2020cites this paper
• Relaxation Therapy for Depression

  2020cites this paper
• Exploring Nonmotor Neuropsychiatric Manifestations of Parkinson Disease in a Comprehensive Care Setting

  2020cites this paper
• Non-pharmacological treatment for Parkinson disease patients with depression: a meta-analysis of repetitive transcranial magnetic stimulation and cognitive-behavioral treatment

  2020cites this paper
• Prolactin changes during electroconvulsive therapy: A systematic review and meta-analysis.

  2020cites this paper
• Electroconvulsive Therapy for Parkinson's Disease: A Systematic Review and Meta‐Analysis

  2020cites this paper
• Effectiveness of Electroconvulsive Therapy in Patients With Advanced Parkinson Disease

  2020cites this paper
• Can ECT Improve the Motor Symptoms of a Neurological Disease? A Case of Dopa-Responsive Dystonia

  2020cites this paper
• Precision ECT for major depressive disorder: A review of clinical factors, laboratory, and physiologic biomarkers as predictors of response and remission

  2019cites this paper
• Regularly monitor neuropsychiatric symptoms in Parkinson’s disease and adjust treatment as necessary

  2019cites this paper
• Drug treatment strategies for depression in Parkinson disease

  2019cites this paper
• Uses of Electroconvulsive Therapy in Conditions Other than Major Depressive Episode

  2019cites this paper
• Utilisation d'un arbre décisionnel permettant d'optimiser les paramètres de stimulation afin d'améliorer la tolérance cognitive de l'électroconvulsivothérapie : étude de faisabilité

  2019cites this paper
• [Electroconvulsive therapy: 80 years of use in psychiatry].

  2019cites this paper
• Regularly monitor neuropsychiatric symptoms in Parkinson’s disease and adjust treatment as necessary

  2019cites this paper
• When time is of the essence: Managing care in emergency situations in Parkinson's disease.

  2019cites this paper
• When to consider electroconvulsive therapy (ECT)

  2019cites this paper
• Acute Microglial Responses to Single Non-Epileptogenic vs. Epileptogenic Seizures in Mouse Hippocampus

  2019cites this paper
• Parkinson's disease: Diagnosis and appreciation of comorbidities.

  2019cites this paper
• Depression in the medically ill

  2019cites this paper
• L’électroconvulsivothérapie en psychiatrie et neurologie

  2019cites this paper
• Advances in Management of Neuropsychiatric Syndromes in Neurodegenerative Diseases

  2019cites this paper
• ECT in Neuropsychiatric Disorders

  2019cites this paper
• Psychiatric Symptoms Comorbid with Neurological Syndromes

  2019cites this paper
• Neuromodulation Interventions: ECT and rTMS – Work-Up, Preparation, and Posttreatment Care + Ketamine in Inpatient Psychiatry

  2019cites this paper
• When All Else Fails: The Use of Electroconvulsive Therapy for Conditions Other than Major Depressive Episode.

  2018cites this paper
• The Use of Electroconvulsive Therapy in Late-Life Psychiatric Disorders

  2018cites this paper
• Effectiveness of Electroconvulsive Therapy (ECT) in Parkinsonian Symptoms: A Case Series.

  2018cites this paper
• Anesthesia for Electroconvulsive Therapy: an Update

  2018cites this paper
• Pharmacotherapy, Somatic Therapies, and Psychotherapy in Late Life

  2018cites this paper
• Assessment and Management of Neuropsychiatric Symptoms in Parkinson’s Disease

  2018cites this paper
• Systematic review of the efficacy of non-pharmacological interventions in people with Lewy body dementia

  2017influential citation
• Treatment of Nonmotor Symptoms in Parkinson's Disease.

  2017cites this paper
• Neurocognitive Disorders in Geriatric Psychiatry.

  2017cites this paper
• Management of Depression in Parkinson's Disease: A Systematic Review

  2017cites this paper
• A practical approach to detection and treatment of depression in Parkinson disease and dementia.

  2017cites this paper
• Electroconvulsive Therapy in Geriatric Psychiatry: A Selective Review.

  2017cites this paper
• Introducing a new volume of Neurodegenerative Disease Management.

  2017cites this paper
• Nonmotor Symptoms in Parkinson's Disease

  2017cites this paper
• Psychotropic Drug Development Strategies that Target Neuropsychiatric Etiologies in Alzheimer's and Parkinson's Diseases

  2016cites this paper
• Psychotropic Drug Development Strategies that Target Neuropsychiatric Etiologies in Alzheimer ’ s and Parkinson ’ s Diseases

  2016cites this paper
• Therapy in Practice: Assessment and Management of Neuropsychiatric Symptoms in Parkinson’s Disease

  year unknowncites this paper